(Q38890008)

English

Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling (English)

1 reference

Europe PubMed Central

7 September 2017

reperfusion injury

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michael G. Irwin

9

1 reference

Europe PubMed Central

7 September 2017

author name string

Yanan Liu

1

1 reference

Europe PubMed Central

7 September 2017

Jiqin Jin

2

1 reference

Europe PubMed Central

7 September 2017

Shigang Qiao

3

1 reference

Europe PubMed Central

7 September 2017

Shaoqing Lei

4

1 reference

Europe PubMed Central

7 September 2017

Songyan Liao

5

1 reference

Europe PubMed Central

7 September 2017

Zhi-Dong Ge

6

1 reference

Europe PubMed Central

7 September 2017

Haobo Li

7

1 reference

Europe PubMed Central

7 September 2017

Gordon Tin-Chun Wong

8

1 reference

Europe PubMed Central

7 September 2017

Zhengyuan Xia

10

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

1 August 2015

1 reference

Europe PubMed Central

7 September 2017

Clinical Science

1 reference

Europe PubMed Central

7 September 2017

129

1 reference

Europe PubMed Central

7 September 2017

4

1 reference

Europe PubMed Central

7 September 2017

331-344

1 reference

Europe PubMed Central

7 September 2017

Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Selective inhibition of protein kinase C β2 attenuates the adaptor P66 Shc-mediated intestinal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

PKCbeta modulates ischemia-reperfusion injury in the heart

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

PKCbeta regulates ischemia/reperfusion injury in the lung

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

The protein kinase C-beta inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Blockade of PKCβ protects against remote organ injury induced by intestinal ischemia and reperfusion via a p66shc-mediated mitochondrial apoptotic pathway.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Myocyte apoptosis in heart failure.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Apoptosis is not involved in the mechanism of myocardial dysfunction after resuscitation in a rat model of cardiac arrest and cardiopulmonary resuscitation

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Role of apoptosis in reperfusion injury

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Role of the mitochondrial permeability transition in myocardial disease

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition.

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

1 reference

https://api.crossref.org/works/10.1042%2FCS20140789

21 January 2018

Identifiers

10.1042/CS20140789

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38890008&oldid=1794074134"